Evaluation of the Effect of Fluvastatin 40 mg (b.i.d.) in the Prevention of the Development of Vasculopathy of the Graft in de Novo Renal Transplant Patients Transplant

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2001

Primary Completion Date

October 31, 2007

Conditions

Graft Vasculopathy

Interventions

DRUG

Fluvastatin

Graft vasculopathy

Trial Locations (1)

Novartis Investigative Site, Barcelona